logo

Global Pain Management Devices Market Size (2024 - 2029)

The pain management devices market is projected to experience significant growth over the forecast period, driven by increased demand for devices due to the rising incidence of chronic diseases and the impact of the COVID-19 pandemic. The pandemic initially hindered market expansion, but the subsequent rise in pain management needs, particularly for conditions exacerbated by COVID-19, spurred market recovery. Additionally, the growing prevalence of cancer and cardiovascular diseases, which often require pain management solutions, further contributes to the market's expansion. Despite these positive trends, challenges such as patient preference for medication over devices and limited awareness may impede market growth.

Home Market Analysis Healthcare Research Medical Devices Research Treatment Equipment Research Pain Management Devices Industry Market Size

Market Size of Global Pain Management Devices Industry

pain management devices market size
Study Period 2019 - 2029
Market Size (2024) USD 10.64 Billion
Market Size (2029) USD 16.89 Billion
CAGR (2024 - 2029) 9.70 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

pain management devices market share

*Disclaimer: Major Players sorted in no particular order

Pain Management Devices Market Analysis

The Global Pain Management Devices Market size is estimated at USD 10.64 billion in 2024, and is expected to reach USD 16.89 billion by 2029, growing at a CAGR of 9.70% during the forecast period (2024-2029).

COVID-19 pandemic has had a substantial impact on the pain management devices market initially. The lockdown and strict laws imposed by the government impacted the growth of the pain management devices market.Due to some unforeseen reasons, the growth of this market was severely obstructed during the initial COVID-19 phase. However, the market gained traction due to the significant increase in infusion appointments, and ablation procedures which increased the market for pain management devices globally. Also, most of the pain management devices were deemed to be not so urgent, also all the outpatient and interventional procedures were reduced due to the strict lockdown imposed by the government, and thus the pain management device market was greatly impacted.

A significant increase in COVID-19 cases had also indirectly increased the number of patients suffering from pain worlwide. It was reported that pain was the first symptom of COVID-19, including myalgias, back pain, and headache. For instance, Best Practice and Research in Clinical Anaesthesiology, July 2020, reported that the majority of the COVID-19 patients had musculoskeletal, back pain, and headaches as a symptom. In another instance, the journal Scientific Reports, states that post-covid pain scores increased to 6 on a 10 scale as compared to pre-covid which was 5 on a 10. To manage and overcome the pain associated with COVID-19, people were more drifted towards pain management devices rather than medicines due to their less severe effects which subsequently led the healthcare industry to increase the manufacture of the pain management devices, which has driven this market.

The rise in cases of chronic diseases such as cancer and other cardiovascular diseases also boosted these devices to manage pain well, which has driven the pain management devices market. For instance, as per the data published by World Health Organization about 10 million deaths due to cancer were reported in 2020. The incidence of cancer is rising dramatically over the past few years and chronic pain associated as a symptom of this disease is also increasing, which is directly driving the pain management devices market.

One of the pain management device, pain controlled analgesia (PCA) pumps, are used to manage post-operative pain to overcome the pain associated with spine surgeries and some critical joint surgeries. For instance, National Spinal Cord Injury Statistical Center (NSCISC) 2021 datasheet has accounted the annual incidence of spinal cord injuries at 60 cases per million. With the increasing number of these cases, and a number of surgical procedures performed the demand for infusion and PCA pumps has significantly increased and thus has driven the pain management devices market.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. However, still few patients prefer pain management drugs over devices due to a lack of awareness which may cause hindrance to the management devices market. Also, these devices are used for the treatment of second-line of therapy to overcome pain, which is another challenge for this market.

Pain Management Devices Industry Segmentation

As per the scope of this study, pain is defined as an unpleasant sensation in the body due to tissue. Pain management devices are instruments that are meant to alleviate pain. The Pain Management Devices Market is segmented by Product Type (Neurostimulation Devices, Infusion Pumps, and Ablation Devices), Application (Musculoskeletal, Cancer Pain, Neuropathic Pain, Facial Pain and Migraine, and Others), End-users (Physiotherapist Centers, Hospitals Clinics, and Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the above segments. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (USD)for the above segments

Need A Different Region Or Segment?
Customize Now

Global Pain Management Devices Market Size Summary

The pain management devices market is poised for significant growth over the forecast period, driven by a combination of factors including the rising prevalence of chronic diseases such as cancer and cardiovascular conditions, and the increasing incidence of neuropathic pain. The COVID-19 pandemic initially disrupted the market due to lockdowns and reduced outpatient procedures, but it later spurred demand as pain became a common symptom among infected individuals. This shift led to a greater reliance on pain management devices over traditional medications, which are often associated with adverse side effects. The market is characterized by a diverse range of devices, including pain-controlled analgesia pumps and neurostimulation devices, which are gaining traction due to their effectiveness in managing post-operative and chronic pain.

North America currently dominates the pain management devices market, supported by advanced technological infrastructure, a high prevalence of chronic pain conditions, and a robust healthcare system that incorporates these devices into treatment protocols. The United States, in particular, shows a high demand for pain management solutions due to its large population suffering from chronic and neuropathic pain. The market is fragmented with numerous global and regional players, including Abbott, Baxter International Inc, and Nevro Corp, who are actively innovating and expanding their product offerings. Partnerships and new product launches, such as the collaboration between Coach Care and Nexstim NBT System, are expected to further enhance market growth by introducing advanced monitoring and therapeutic solutions.

Explore More

Global Pain Management Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 The advent of Innovative and Technologically Advanced Pain Management Devices

      2. 1.2.2 Increase in Adoption of Pain Management Devices

      3. 1.2.3 Rise in Geriatric Population

    3. 1.3 Market Restraints

      1. 1.3.1 Preferable use of medications for pain management

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION( Market Size by Value)

    1. 2.1 By Product Type

      1. 2.1.1 Neurostimulation Devices

      2. 2.1.2 Infusion Pumps

      3. 2.1.3 Ablation Devices

    2. 2.2 By Application

      1. 2.2.1 Musculoskeletal

      2. 2.2.2 Cancer Pain

      3. 2.2.3 Neuropathic Pain

      4. 2.2.4 Facial Pain and Migraine

      5. 2.2.5 Other

    3. 2.3 By End-User

      1. 2.3.1 Physiotherapy Centers

      2. 2.3.2 Hospitals and Clinics

      3. 2.3.3 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Pain Management Devices Market Size FAQs

The Global Pain Management Devices Market size is expected to reach USD 10.64 billion in 2024 and grow at a CAGR of 9.70% to reach USD 16.89 billion by 2029.

In 2024, the Global Pain Management Devices Market size is expected to reach USD 10.64 billion.

Pain Management Devices Market Report Snapshots

Pain Management Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)